Cargando…
Interleukin 22 and 6 serum concentrations decrease under long-term biologic therapy in psoriasis
INTRODUCTION: Psoriasis, affecting approximately 2% of the worldwide population, is a chronic, inflammatory skin disease in which overexpression of proinflammatory cytokines is observed. Most of the available data on the influence of antipsoriatic therapy on the cytokine serum concentration are inco...
Autores principales: | Olejniczak-Staruch, Irmina, Narbutt, Joanna, Bednarski, Igor, Woźniacka, Anna, Sieniawska, Joanna, Kraska-Gacka, Marzena, Śmigielski, Janusz, Lesiak, Aleksandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7675072/ https://www.ncbi.nlm.nih.gov/pubmed/33240010 http://dx.doi.org/10.5114/ada.2020.100481 |
Ejemplares similares
-
Are interleukin-15 and -22 a new pathogenic factor in pustular palmoplantar psoriasis?
por: Lesiak, Aleksandra, et al.
Publicado: (2016) -
AntiTNF-alpha therapy normalizes levels of lipids and adipokines in psoriatic patients in the real-life settings
por: Olejniczak-Staruch, Irmina, et al.
Publicado: (2021) -
Ingenol mebutate treatment in actinic keratosis – clinical effectiveness and potential side effects
por: Lesiak, Aleksandra, et al.
Publicado: (2019) -
Serum concentration of matrix metalloproteinases and angiogenic factors in patients with venous leg ulcers
por: Kolano, Paweł, et al.
Publicado: (2021) -
Omalizumab for urticaria treatment in clinical practice: a case series
por: Lesiak, Aleksandra, et al.
Publicado: (2018)